SUMMARY Basolateral membrane (BLM) enriched fraction was isolated from homogenized rat kidney cortex by differential centrifugation. We also obtained a fraction enriched in plasma membrane (PM). The morphology of the Isolated BLM fragments was studied by transmission and freeze fracture electron microscopy. The relative specific activity of Na + -K + -ATPase was enriched 7-fold, while that of marker enzymes for PM, endoplasmic reticulum, and lysosomes was lower than In the crude bomogenate. There was a 10-fold difference in the ratios of activities of Na + -K + -ATPase to Mg* + -ATPase in the BLM and in the PM enriched fractions. Kallikrein activity was determined with S-2266 substrate and by radioimmunoassay of kinin released. It was low In the BLM fraction prior to adding detergent, but Triton X-100 increased the activity 12 to 16-fold. Both free trypsin and Sepharose 4B-bound insoluble trypsin Increased kallikrein activity 2-to Mold in both the membrane-bound and soluble fractions, probably by activating a prekallikrein. The results were Interpreted that the kallikrein studied originated from the distal tubular BLM. R ENAL distribution of enzymes that release or inactivate kinins has been studied by a number of investigators. 1 ' * The glomerulus has little or no kallikrein and kininase II activity.* Most, but not all, of kininase II or converting enzyme is concentrated on the brush border of the proximal tubules.*""* Urinary kallikrein enters the nephron at the level of the distal tubules.
R ENAL distribution of enzymes that release
or inactivate kinins has been studied by a number of investigators. 1 ' * The glomerulus has little or no kallikrein and kininase II activity.* Most, but not all, of kininase II or converting enzyme is concentrated on the brush border of the proximal tubules.*""* Urinary kallikrein enters the nephron at the level of the distal tubules. 1 Kallikrein in the kidney is bound to plasma membrane, as shown by the isolation membrane fractions enriched in kallikrein 1 and by the kallikrein activity expressed on the surface of isolated, suspended kidney cells. 8 Immunofluorescence studies first indicated that kallikrein is located on the luminal side of the distal part of the nephron,* but recently it was suggested that kallikrein may be more uniformly distributed in these cells. 7 ' Kallikrein is released by vasoactive agents given into the renal artery, 10 and appears in the renal lymph and venous effluent. 11 It was suggested that renal kallikrein affects renal vascular resistance." These findings are hard to reconcile with a primary localization of kallikrein on the luminal side of the nephron.
Because of the reported discrepancies in functions, release and localization of renal kallikrein, we isolated a basolateral membrane (BLM) enriched fraction from the rat kidney and studied enzymes in this fraction. This communication describes the technique used for the separation of a BLM enriched fraction containing bound prekallikrein and kallikrein. The properties of the BLM-bound kallikrein were compared with those of a kallikrein in the plasma membrane (PM) enriched fraction. CaCl t and 0.25 M sucrose). After brief centrifugation (200 X g for 5 min), the resultant supernatant was filtered through 180 Teflon mesh. The filtrate was then centrifuged at 2,000 X g for 20 minutes. The pellet was resuspended in the homogenate buffer, washed, and recentrifuged 10 times. The final precipitate was suspended in homogenate buffer. This fraction was centrifuged at 90,000 X g for 2 hours in a Beckman SW 27 rotor of the ultracentrifuge over a discontinuous density gradient consisting of 1.16, 1.18 and 1.20 g/ml, sucrose, in 5 mM Tris HC1, pH 7.4, 0.5 mM CaCl,. The layer at the interface of the 1.16 and 1.18 g/ml sucrose solutions was collected. Then the density of the bottom fraction was adjusted to 1.22 g/ml with the addition of 65% sucrose, 5 mM Tris HC1, pH 7.4, 0.5 mM CaClj. The centrifugation was repeated at 90,000 X g for 2 hours, and at the layer on the interface of 1.16 and 1.18 g/ml sucrose solution was collected. After dilution to isotonicity with 5 mM Tris HC1, pH 7.4, and 0.5 mM CaCl,, the membrane fraction was sedimented at 22,000 X g in 20 minutes. The pellet was suspended in 10 mM Tris HC1, pH 7.4 and 0.25M sucrose, washed and recentrifuged at 22,000 X g for 20 minutes. The resultant pellet, the BLM rich fraction, was suspended in 10 mM Tris HC1 pH 7.4, containing 0.25 M sucrose. For the hypotonic washing, the fraction was suspended in 10 mM Tris HC1, pH 8.6, and 0.5 mM CaCl,, washed, and centrifuged at 100,000 X g for 45 minutes. It was then suspended in 1 mM Tris HC1, pH 8.6 containing 0.5 mM CaCl a , and centrifuged at 100,000 X g for 45 minutes. This step was followed by washing twice with 10 mM Tris HC1 pH 7.4 and 0.25 M sucrose and centrifugation at 22,000 X g for 20 minutes. The final washed BLM pellet was suspended in 10 mM Tris HC1, pH 7.4 containing 0.25 M sucrose. 1 *-" Washed basolateral membrane was solubilized by incubation in 0.1% Triton X-100 for 30 minutes at 4°C and centrifuged at 105,000 X g for 60 minutes.
Assays
The following marker enzymes were assayed as reported previously:
1 -14 5'-nucleotidase, Na-KATPase, Mg-ATPase, alkaline phosphatase, acid phosphatase, glucose-6-phosphatase, j8-glucuronidase, and aminopeptidase A. The substrates were: adenosine-5-monophospate, ATP Na,, p-nitrophenyl phosphate, glucose-6-phosphate, p-nitrophenyl glucuronide, and aspartyl-0-naphthylamide respectively.
The activity of kallikrein was assayed with S-2266 1 *" 1 * and by determining the kinin released from heated dog plasma by radioimmunoassay. The incubation mixture contained 0.1M Tris HC1, pH 8.5, and kininase inhibitors SQ 14,225, (captopril 10"* M), EDTA (5 X 10"' M) and o-phenanthroline (10"' M).
Sepharose-4B-bound trypsin was prepared by using Sepharose 4B activated by CNBr according to the manufacturer's recommended procedure. Approximately 75% of trypsin was bound to gel and approximately 20% of the activity of trypsin was retained. The activity of trypsin was measured by using S-2266 as substrate at pH 9.0. Sepharose 4B-bound trypsin was suspended in 0.1 M sodium acetate buffer, pH 4.0, containing 1M NaCl and Na azide and stored at 4°C. An aliquot of washed or solubilized BLM was treated with trypsin by mixing 10 ng of free trypsin or equivalent activity of bound trypsin and incubating at room temperature for 60 minutes in 10 mM Tris at pH 7.4 in tubes rotated on a turntable. After incubation with soluble trypsin, 20 jtg of soybean trypsin inhibitor was added to stop the reaction. This amount of inhibitor completely inhibited all trypsin activity. Samples with bound trypsin were immediately centrifuged at 250 X g for 3 minutes, and the supematants were removed and used in assays. No trypsin activity was detected in the supernatants after Sepharose-4B bound trypsin was sedimented.
Electron Microscopy
The pellet of basolateral plasma membrane was fixed in 3% glutaraldehyde for several days and postfixed in 1% osmium tetroxide for 1 hour. Both fixatives contained 0.1 M phosphate buffer and 5% sucrose, pH 7.3. Following dehydration through graded alcohol and propylene oxide, the sample was embedded in Epon-Araldite." Thin sections were stained and sectioned for electronmicroscopy, with uranyl acetate, and lead citrate. They were observed and photographed in the JEOL 100S electron microscope.
Freeze-fracture replication was executed in a Denton DFE-3 freeze-etch module. Tissue from the cortex of rat kidney and BLM pellet were fixed in 3% glutaraldehyde for several days. For cryoprotection, specimens were placed overnight in 30% glycerol containing 1% glutaraldehyde. The specimens were loaded into apposed-specimen gold holders and dropped into Freon 22 at -165°C. They were fractured at -105°C and slightly etched while the temperature was allowed to rise to -100°C. Platinum shadowing was carried out using an electron beam gun of our own design. 1 * Replicas were cleaned in commercial bleach containing 1.3% sodium hypochlorite and rinsed three times in distilled water. The replicas were photographed in the JEOL 100C electron microscope. The electron microscope sheet film was reversal processed so that shadows appear black on the prints. 40 The details of separating plasma membrane (PM) and endoplasmic reticulum (ER) 1 *" 16 enriched fractions from the homogenized rat kidney cortex were given in the previous communications from this laboratory. Table 2 summarizes the distribution of marker enzymes in the fractions isolated from homogenized rat kidney cortex. Fraction II BLM had only 2.5% of the total protein but the relative specific activity of Na + -K + -ATPase increased sevenfold, with a yield of 18%. Repeated washing did not change the activity of the enzyme in the BLM fraction. In contrast, the relative specific activity of alkaline phosphatase, a PM marker enzyme and that of glucose-6-phosphatase, an ER marker, decreased in the BLM fraction. Aminopeptidase A activity also decreased, while 5'-nucleotidase, a membrane-bound enzyme, was enriched 2.4-fold. The relative specific activities of acid phosphatase, and /3-glucuronidase, lysosomal markers decreased from 1 to 0.3 in the washed BLM fraction (not shown).
Results

Marker Enzymes
Electronmicroscopy
Transmission electron microscopy revealed that the BLM fraction consisted of vesicles ranging from 0.2 to 2.0 nm in size ( fig. 1 ). While the majority of vesicles appeared empty, some contained smaller vesicles. These smaller vesicles may have been trapped as the BLM broke apart and vesiculated during homogenization. In freeze-fracture images large membrane sheets were seen ( fig. 2) , which appeared to form multiple sheaths around each other. This arrangement is very similar to the basal plasma membrane infoldings seen in distal tubules in situ ( fig. 3) . Occasionally, both in transmission electron microscopy and in freeze-frac- ture, mitochondria were seen wrapped in membrane in the fractions as in the folds of basal membrane in the intact distal tubules. Table 3 shows the distribution of kallikrein activity among the isolated renal fractions. As measured with S-2266 substrate, about 30% of the kallikrein activity in the homogenate was recovered in the washed 2,000 X g sediment. Triton X-100 did not increase the activity of kallikrein in the crude homogenate or in the first sediment. However, it enhanced kallikrein activity to 8-fold in the BLM fraction, but less in the other fractions isolated by differential centrifugation. The BLM enriched fraction had about 10% of the total kallikrein activity of the rat kidney, after solubilization with a detergent, but without Triton only about 0.9-1.2%. This indicates that it contains mainly inactive, bound kallikrein. Table 4 compares the results obtained by measuring kallikrein activity with S-2266 substrate and by determining the amount of kinin released by radioimmunoassay. For the sake of comparison, the results of experiments with kallikrein bound to PM fraction are included in table 4. Triton X-100 solubilized kallikrcin since recentrifugation of BLM or PM fractions at 105,000x g did not decrease the activity in the supernatant. The increase in the rate of hydrolysis of the tripeptide substrate, S-2266, by Triton is in good agreement with the results of radioimmunoassay. While the BLM kallikrein activity increased after detergent treatment 12.3 and 16.4-fold with either substrate, PM kallikrein activity was enhanced only about four-fold under the same conditions. That the BLM fraction contained prekallikrein was shown in experiments where soluble trypsin or Sepharosebound trypsin was added to the incubation mixture. Free or bound trypsin increased kallikrein activity both in the membrane fraction and after solubilization. A discrepancy in the activation was noted only when kallikrein activity was measured with S-2266 after free trypsin was added to the BLM fraction. This disproportional increase in S-2266 hydrolysis by trypsin may be due to activation of a second enzyme in the fraction that cleaves S-2266 but is not necessarily identical with kallikrein. (table 5) To differentiate PM from BLM enriched fraction, we compared the ratios of activity of Na + K + -ATPase to Mg a+ ATPase in the isolated BLM fraction and to the ratios obtained in the PM-and ER-enriched fractions. While the ratio of activities in the washed BLM fraction was 2.6, it was 0.22 in the PM fraction. This is taken as an added evidence that the fraction was indeed enriched in basolateral membrane, since Na + K + -ATPase is localized on the BLM membrane. 21 " 28 Discussion We report here that kallikrein is present in the BLM-enriched fraction of the rat kidney, mainly in inactive form. The 18 different iso-and hypotonic washings and sedimentation procedures used should preclude entrapment of kallikrein or an unspecific adsorption of soluble kallikrein on membrane vesicles.
Kallikrein
Most of the kallikrein in the BLM fraction was inactive, while in the PM fraction a substantial amount of PM-kallikrein was in active form. 1 *" 16 Bound kallikrein is activated by trypsin and Triton X-100. However, PM kallikrein activity was increased by Triton X-100 fourfold while BLM kallikrein activity was enhanced much more (tables 3 and 4). Kallikrein in the BLM fraction, prior to Triton treatment, released about 0.7 ng of bradykinin per minute, but 24 ng after solubilization and activation. The activity in the PM fraction was still higher, however, after a detergent was added.
Additional data indicate that kallikrein in BLM fraction is also inhibited by antiserum to urinary kallikrein. That BLM prekallikrein would originate from a contaminating PM fraction is unlikely because among others, the physical properties of activated BLM prekallikrein are also different. (Yamada and Erd6s, unpublished.) We assume that kallikrein in the PM fraction came mostly from the apical membrane of the distal tubules. The high alkaline phosphatase activity in the PM fraction also supports this assumption.
Studies with marker enzymes also suggested differences between the BLM-and PM-enriched fractions. The ratios of activities of Na+K + -ATPase to Mg 2 " 1 --ATPase differed 10-fold in the PM and BLM fractions; Na + K + -ATPase activity was concentrated in the BLM fraction. This is in agreement with the findings of others, who localized this enzyme on the BLM of the distal tubules by a histochemical technique.
-M
The plasma membrane marker enzyme alkaline phosphatase activity was enriched 11-fold in the PM The PM fraction, which was homogenized harsher than the BLM, contained mostly empty vesicles.
14 The BLM fraction also contained vesicles of various sizes, as shown by transmission electronmicroscopy, but freeze fracture showed intact segments with infolding of the membranes. Electron microscopic studies support our notion that a large percentage of our BLM fraction originates from the infoldings of distal membrane in convoluted tubules. Our procedure seems to preserve considerably larger membrane fragments and vesicles than the method of Ebel et al.,
M which yielded vesicles smaller than 1 /im.
The ultrastructure of the distal tubular cells indicates that the surface area of BLM is larger than the PM on the luminal side. In secretory glands kallikrein is present in cells that are rich in mitochondria and contain infoldings of cell membranes, a structure usually associated with water and ion transport." The basal part of the epithelium in distal tubules, which faces the peritubular capillaries, also shows concentrated mitochondria in addition to infoldings of membranes." The isolated BLM fraction contained some mitochondria with the membrane fragments enveloped around them even after many washings. Hypothetically, there could be a functional relationship between kallikrein on BLM membrane and enzymes in the mitochondria.
Corthorn et al. u found a prekallikrein in human urine that was activated by trypsin. Prekallikreins in the rat kidney may be activated by serine proteases that cleave peptide bonds at a basic amino acid residue similar to trypsin; plasmin may be such an enzyme (Yamada and Erd5s, unpublished) . A location of kallikrein on the basal membrane suggests access to plasma kininogen in the extracellular space. In addition, BLM kallikrein could be released in the renal lymph and venous effluent. Kinins released in the kidney may influence renal vascular resistance.
In conclusion, a significant amount of the total kallikrein activity in the rat kidney is present as prekallikrcin and as a membrane-bound but inactive enzyme in the BLM fraction. This BLM kallikrein may be the source of renal kallikrein that appears in renal lymph and venous effluent of the perfused kidney, while kallikrein and prekallikrein bound in the PMenriched fraction may be excreted in the urine.
